11 results on '"Myall, Daniel J."'
Search Results
2. Higher perceived stress and exacerbated motor symptoms in Parkinson's disease during the COVID-19 lockdown in New Zealand.
- Author
-
Blakemore RL, Pascoe MJ, Horne KL, Livingston L, Young BN, Elias B, Goulden M, Grenfell S, Myall DJ, Pitcher TL, Dalrymple-Alford JC, Le Heron CJ, Anderson TJ, and MacAskill MR
- Subjects
- Case-Control Studies, Disease Progression, Exercise, Gait, Humans, Hypokinesia etiology, New Zealand, Parkinson Disease complications, Postural Balance, SARS-CoV-2, Surveys and Questionnaires, Tremor etiology, COVID-19 prevention & control, Parkinson Disease psychology, Stress, Psychological complications
- Abstract
Aims: Stress plays a key role in Parkinson's disease (PD) by acting on the dopaminergic system and worsening patients' motor function. The impact of New Zealand's strict lockdown measures to contain COVID-19 on perceived stress and PD motor symptoms remains unknown. Here we examined the relationship between perceived levels of stress, changes in physical activity levels and PD motor symptoms during lockdown., Methods: During lockdown, 134 participants with PD and 49 controls completed a survey assessing perceived stress, self-reported changes in PD motor symptoms and physical activity duration and intensity prior to and during lockdown., Results: Perceived stress was higher in PD than controls, and in those reporting a worsening of tremor, balance/gait, dyskinesia and bradykinesia compared to those indicating no change during the COVID-19 lockdown. These effects were not modulated by physical activity., Conclusions: Reducing stressors may be an important adjunct treatment strategy to improve motor function in PD., Competing Interests: Nil.
- Published
- 2021
3. Childbirth and Delayed Parkinson's Onset: A Reproducible Nonbiological Artifact of Societal Change.
- Author
-
MacAskill MR, Myall DJ, Shoorangiz R, Anderson TJ, and Pitcher TL
- Subjects
- Age of Onset, Artifacts, Child, Cohort Studies, Female, Humans, Male, New Zealand epidemiology, Pregnancy, Parkinson Disease diagnosis, Parkinson Disease epidemiology
- Abstract
Background: Uncontrolled studies have reported associations between later Parkinson's disease onset in women and a history of giving birth, with age at onset delayed by nearly 3 years per child. We tested this association in two independent data sets, but, as a control to test for nonbiological explanations, also included men with PD., Methods: We analyzed valid cases from the Parkinson's Progressive Markers Initiative incident sample (145 women, 276 men) and a prevalent sample surveyed by the New Zealand Brain Research Institute (210 women, 394 men)., Results: The association was present in both women and men in the Parkinson's Progressive Markers Initiative study, and absent in both in the New Zealand Brain Research Institute study. This is consistent with generational differences common to men and women, which confound with age at onset in incident-dominant samples., Conclusions: Despite being replicable in certain circumstances, associations between childbirth and later PD onset are an artifact of generational cohort differences. © 2020 International Parkinson and Movement Disorder Society., (© 2020 International Parkinson and Movement Disorder Society.)
- Published
- 2020
- Full Text
- View/download PDF
4. Response to "Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms".
- Author
-
Horne KL, Myall DJ, MacAskill MR, Anderson TJ, and Dalrymple-Alford JC
- Subjects
- Demography, Disease Progression, Humans, Cognitive Dysfunction, Dementia psychology, Parkinson Disease psychology
- Abstract
A recent paper, "Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms" (McDermott et al., 2017), provides an interesting comparison of the influence of different criteria for Parkinson's disease with mild cognitive impairment (PD-MCI) on progression to dementia (PDD). Unfortunately, McDermott et al. (2017) incorrectly stated that "only 21% of PD-MCI participants (identified with a 1.5 SD cut-off) converted to PDD within four years" (p.6) in our study (Wood et al., 2016). However, the important point made by Wood et al. (2016) was that the proportion of conversions to PDD was 51% when the PD-MCI diagnosis required a minimum of two 1.5 SD impairments within any single cognitive domain, whereas additional PD-MCI patients classified with one impairment at 1.5 SD in each of the two domains (but never two impairments in the same domain) had a non-significant risk of dementia relative to non-MCI patients (11% vs. 6% converted, respectively). Our PDD conversion rate was 38% when combining both 1.5 SD criteria (21/56 PD-MCI patients vs. 4/65 non-MCI patients converted); McDermott et al. (2017) found a 42% conversion rate over three years for similarly described PD-MCI patients (10/24 PD-MCI patients vs. 0/27 non-MCI patients converted). Our study was also part of a multinational study (n = 467) showing that PD-MCI has predictive validity beyond known demographic and PD-specific factors of influence (Hoogland et al., 2017). All three studies found that multiple cognitive domain impairments are common in PD-MCI. Nonetheless, the research community needs to clarify the association between PD-MCI subtypes and, especially, the optimal cognitive markers for dementia risk in PD patients.
- Published
- 2018
- Full Text
- View/download PDF
5. Parkinson's disease across ethnicities: A nationwide study in New Zealand.
- Author
-
Pitcher TL, Myall DJ, Pearson JF, Lacey CJ, Dalrymple-Alford JC, Anderson TJ, and MacAskill MR
- Subjects
- Age Factors, Aged, Bayes Theorem, Female, Humans, Incidence, International Classification of Diseases, Male, Middle Aged, New Zealand epidemiology, New Zealand ethnology, Parkinson Disease diagnosis, Parkinson Disease therapy, Prevalence, Ethnicity, Parkinson Disease epidemiology, Parkinson Disease ethnology
- Abstract
Background: New Zealand is an ethnically diverse country with a unified national prescribing system. This provides a good framework to use drug-tracing methodology to establish the prevalence and incidence of Parkinson's disease across different ethnic groups. The objective of this study was to determine the prevalence and incidence of Parkinson's disease in the major ethnic groups in New Zealand., Methods: Information on Parkinson's disease-related medications was extracted from the national Pharmaceutical Collection of community-dispensed medications for the period January 1, 2005, to December 31, 2014. Diagnoses for a large subset of individuals were independently determined through national mortality and hospital admissions data sets. We used a Bayesian model, accommodating uncertainty and bias, to estimate the number of people with Parkinson's disease., Results: We found the highest rate of Parkinson's disease in the European ethnic group and the lowest rate in the indigenous Māori. The 2006-2013 age-standardized incidence (per 100,000 population per year) was European, 33; Asian, 28; Pasifika, 27; Māori, 20. The 2013 age-standardized prevalence (per 100,000 population) was European, 223; Asian, 174; Pasifika, 160; Māori, 114., Conclusions: There is a differential occurrence of Parkinson's disease across the major ethnic groups within the New Zealand population, with indigenous Māori showing the lowest incidence. Varying susceptibility profiles, gene-environment interactions, and inequalities in accessing health care may play a role in the variation in rates of Parkinson's disease in New Zealand. © 2018 International Parkinson and Movement Disorder Society., (© 2018 International Parkinson and Movement Disorder Society.)
- Published
- 2018
- Full Text
- View/download PDF
6. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
- Author
-
Almuqbel M, Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Wood KL, Keenan RJ, Dalrymple-Alford JC, and Anderson TJ
- Subjects
- Aged, Aged, 80 and over, Aspartic Acid analogs & derivatives, Aspartic Acid metabolism, Bayes Theorem, Case-Control Studies, Choline metabolism, Cognitive Dysfunction psychology, Creatine metabolism, Dementia psychology, Disease Progression, Female, Humans, Inositol metabolism, Magnetic Resonance Spectroscopy, Male, Middle Aged, Neuropsychological Tests, Parkinson Disease psychology, Superior Sagittal Sinus, Cognitive Dysfunction metabolism, Dementia metabolism, Gyrus Cinguli metabolism, Parkinson Disease metabolism
- Abstract
Introduction: Parkinson's Disease (PD) is classified as a motor disorder, but most patients develop cognitive impairment, and eventual dementia (PDD). Predictive neurobiomarkers may be useful in the identification of those patients at imminent risk of PDD. Given the compromised cerebral integrity in PDD, we investigated whether brain metabolites track disease progression over time., Methods: Proton Magnetic Resonance Spectroscopy (MRS) was used to identify brain metabolic changes associated with cognitive impairment and dementia in PD. Forty-nine healthy participants and 130 PD patients underwent serial single voxel proton MRS and neuropsychological testing. At baseline patients were classified as either having normal cognitive status (PDN, n = 77), mild cognitive impairment (PDMCI, n = 33), or dementia (PDD, n = 20). Posterior cingulate cortex (PCC) was examined to quantify N-acetylaspartate (NAA), choline (Cho), creatine (Cr), and myo-inositol (mI). A hierarchical Bayesian model was used to assess whether cognitive ability and other covariates were related to baseline MRS values and changes in MRS over time., Results: At baseline, relative to controls, PDD had significantly decreased NAA/Cr and increased Cho/Cr. However, these differences did not remain significant after accounting for age, sex, and MDS-UPDRS III. At follow-up, no significant changes in MRS metabolite ratios were detected, with no relationship found between MRS measures and change in cognitive status., Conclusions: Unlike Alzheimer's disease, single voxel MR spectroscopy of the PCC failed to show any significant association with cognitive status at baseline or over time. This suggests that MRS of PCC is not a clinically useful biomarker for tracking or predicting cognitive impairment in Parkinson's disease., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
7. Tracking Parkinson's Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease.
- Author
-
Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Watts R, Keenan RJ, Dalrymple-Alford JC, and Anderson TJ
- Subjects
- Aged, Brain pathology, Cohort Studies, Disease Progression, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Parkinson Disease pathology
- Abstract
Background & Objectives: Cross-sectional magnetic resonance imaging (MRI) suggests that Parkinson's disease (PD) is associated with changes in cerebral tissue volume, diffusion tensor imaging metrics, and perfusion values. Here, we performed a longitudinal multimodal MRI study--including structural, diffusion tensor imaging (DTI), and perfusion MRI--to investigate progressive brain changes over one year in a group of older PD patients at a moderate stage of disease., Methods: Twenty-three non-demented PD (mean age (SD) = 69.5 (6.4) years, disease duration (SD) = 5.6 (4.3) years) and 23 matched control participants (mean age: 70.6 (6.8)) completed extensive neuropsychological and clinical assessment, and multimodal 3T MRI scanning at baseline and one year later. We used a voxel-based approach to assess change over time and group-by-time interactions for cerebral structural and perfusion metrics., Results: Compared to controls, in PD participants there was localized grey matter atrophy over time in bilateral inferior and right middle temporal, and left orbito-frontal cortices. Using a voxel-based approach that focused on the centers of principal white matter tracts, the PD and control cohorts exhibited similar levels of change in DTI metrics. There was no significant change in perfusion, cognitive, or motor severity measures., Conclusions: In a cohort of older, non-demented PD participants, macrostructural MRI detected atrophy in the PD group compared with the control group in temporal and orbito-frontal cortices. Changes in diffusion MRI along principal white matter tracts over one year were found, but this was not differentially affected by PD.
- Published
- 2015
- Full Text
- View/download PDF
8. Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study.
- Author
-
Le Heron CJ, Wright SL, Melzer TR, Myall DJ, MacAskill MR, Livingston L, Keenan RJ, Watts R, Dalrymple-Alford JC, and Anderson TJ
- Subjects
- Aged, Aged, 80 and over, Blood Flow Velocity, Female, Humans, Male, Radiography, Alzheimer Disease diagnostic imaging, Alzheimer Disease physiopathology, Cerebrovascular Circulation, Limbic System blood supply, Limbic System diagnostic imaging, Limbic System physiopathology, Magnetic Resonance Angiography, Parkinson Disease diagnostic imaging, Parkinson Disease physiopathology
- Abstract
Emerging evidence suggests that Alzheimer's disease (AD) and Parkinson's disease dementia (PDD) share neurodegenerative mechanisms. We sought to directly compare cerebral perfusion in these two conditions using arterial spin labeling magnetic resonance imaging (ASL-MRI). In total, 17 AD, 20 PDD, and 37 matched healthy controls completed ASL and structural MRI, and comprehensive neuropsychological testing. Alzheimer's disease and PDD perfusion was analyzed by whole-brain voxel-based analysis (to assess absolute blood flow), a priori specified region of interest analysis, and principal component analysis (to generate a network differentiating the two groups). Corrections were made for cerebral atrophy, age, sex, education, and MRI scanner software version. Analysis of absolute blood flow showed no significant differences between AD and PDD. Comparing each group with controls revealed an overlapping, posterior pattern of hypoperfusion, including posterior cingulate gyrus, precuneus, and occipital regions. The perfusion network that differentiated AD and PDD groups identified relative differences in medial temporal lobes (AD
- Published
- 2014
- Full Text
- View/download PDF
9. "Ocular tremor" in Parkinson's disease: a technology-dependent artifact of universal head motion?
- Author
-
MacAskill MR, Myall DJ, and Anderson TJ
- Subjects
- Female, Humans, Male, Oculomotor Nerve Diseases diagnosis, Oculomotor Nerve Diseases epidemiology, Parkinson Disease diagnosis, Parkinson Disease epidemiology, Tremor diagnosis, Tremor epidemiology
- Published
- 2013
- Full Text
- View/download PDF
10. The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease.
- Author
-
Macaskill MR, Graham CF, Pitcher TL, Myall DJ, Livingston L, van Stockum S, Dalrymple-Alford JC, and Anderson TJ
- Subjects
- Aged, Aged, 80 and over, Analysis of Variance, Dementia complications, Disability Evaluation, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Photic Stimulation, Regression Analysis, Cognition Disorders etiology, Parkinson Disease complications, Reaction Time physiology, Saccades physiology
- Abstract
Studies of saccades in Parkinson's disease (PD) have seldom examined the influence of cognitive status, ranging from normal cognition, through mild cognitive impairment, to dementia. In a large and heterogeneous sample, we examined how motor and cognitive impairment was reflected in the performance of reflexive, visually-guided saccades. We examined 163 people with PD and 47 similar-aged controls. Ninety three of the PD group had normal cognition (PDN), 48 had mild cognitive impairment (PD-MCI), and 22 had dementia (PDD). Pseudo-random targets (amplitudes of 5, 10, 15 and 20 deg and inter-stimulus-intervals ranging from 550 to 1800 ms) were shown in 108 mixed randomised trials, incorporating gap, step, and overlap onset conditions. Analyses were conducted using multi-level regression modeling. Participants were first assessed by continuous measures (Unified PD Rating Scale motor score and the Montreal Cognitive Assessment). Prolonged latency was significantly related to both motor and cognitive impairment, with the cognitive effect being compounded by increasing age. Decreased saccade amplitude, meanwhile, was primarily related to motor impairment. When assessed by discrete cognitive categories, all of the PD groups showed reduced saccadic amplitude relative to controls. Saccadic latencies, meanwhile, were abnormally prolonged only in the PD-MCI and PDD groups (the control and PDN groups were similar to each other). Latency in the overlap task was particularly sensitive to increasing motor and cognitive impairment. We conclude that reflexive saccades in PD are subtly decreased in amplitude even early in the disease process. Prolonged saccade latency, meanwhile, tends to occur later in the disease process, in the presence of more substantial motor and cognitive impairment, and greater age. The progressive impairment of reflexive saccades, and the differential onset of amplitude and latency impairments, may make them a useful objective tool for assessing disease status., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
11. Submovements in visually-guided and memory-guided reaching tasks: changes in Parkinson's disease.
- Author
-
Myall DJ, MacAskill MR, Anderson TJ, and Jones RD
- Subjects
- Biofeedback, Psychology, Biomedical Engineering, Case-Control Studies, Female, Humans, Linear Models, Male, Memory, Models, Neurological, Movement physiology, Parkinson Disease psychology, Psychomotor Performance physiology, Vision, Ocular, Parkinson Disease physiopathology
- Abstract
Movements in people with Parkinson's disease are often hypometric, although we have found that this was not the case in an experimental visually-guided reaching task. We wished to explore our hypotheses that (1) people with Parkinson's disease produce hypometric primary submovements but(2) are able to use visual feedback to accurately reach the target in a single overall movement, and (3) this effect may be greater in memory-guided tasks in which an internal representation of the target location is used instead of a fixation-centered representation of the target.Visually- and memory-guided reaching movements were examined in 22 people with mild to moderate severity Parkinson's disease on medication, along with age-matched and sex-matched controls. Primary submovements were extracted from 5149 movements using a method based upon zero crossings of jerk(3rd derivative of position), with several additional criteria to minimize the detection of submovements due to noise or tremor.There was no difference in the end position of the overall reaching movement between the two groups, although the movement was smaller in the memory-guided task. In contrast,the gain of the primary submovement was smaller in the Parkinson's disease group than the control group, with this difference being greater on the memory-guided task. There was no task effect on the primary submovement gain in the control group.Our results show that the underlying primary submovement in visually-guided movements in people with Parkinson's disease is hypometric, and that the degree of hypometria is even greater in memory-guided movements.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.